| 24.30 Data as of May 24 |  -0.06 / -0.25%Today’s Change | 11.02 Today|||52-Week Range 50.51 | -30.57% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Purdue Pharma Lp |  Buy | 9/07/2012 | 5,416,565 | $14.50 | $78.5M | +32.86% |
Purdue Pharma Lp | Buy | 9/07/2012 | 5,416,565 | $14.50 | $78.5M | +32.86% |
Holtzman Steven H Director |  Sale | 5/29/2012 | 189,303 | $13.00 | $2.5M | +86.92% |
Holtzman Steven H Director | Sale | 5/31/2012 | 57,573 | $13.01 | $749.0K | +86.78% |
Perkins Adelene Q President & Chief Executive Officer | Buy | 12/07/2012 | 76,930 | $5.94 | $457.0K | +7.88% |
Venrock Associates | Sale | 11/27/2012 | 17,648 | $25.28 | $446.1K | -3.53% |
Perkins Adelene Q President & Chief Executive Officer | Buy | 12/07/2012 | 29,432 | $13.59 | $400.0K | +7.88% |
Lindblom Christopher M VP-Accounting & Financial Planning | Sale | 11/26/2012 | 13,885 | $25.73 | $357.3K | -5.41% |
Perkins Adelene Q President & Chief Executive Officer | Buy | 12/07/2012 | 23,070 | $6.25 | $144.2K | +7.88% |
Lindblom Christopher M VP-Accounting & Financial Planning | Buy | 11/26/2012 | 10,000 | $14.33 | $143.3K | -5.41% |
.
